花旗:看好蘋果(AAPL.US)發展前景,上調目標價至200美元
智通財經APP獲悉,花旗分析師Jim Suva重申蘋果(AAPL.US)“買入”評級,目標價由170美元上調至200美元。
分析師指出,繼2021年市場份額有所增長之後,對蘋果產品和服務的需求應該會在2022財年保持“彈性”。分析師認爲,蘋果目前的市值未能充分反映該公司在新產品領域的成績,隨着該公司的VR/AR
耳機可能在明年推出,該股股價應該會有所變化。
此外,分析師表示,雖然對蘋果的監管是一個隱患,但它帶來的是“消息面風險,而非基本面風險”,蘋果股價近期的任何回調都將是一個買入機會。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.